Compounds and Methods for Inhibiting Serotonin Synthesis
Compounds having the structures below that are TPH1 inhibitors are provided: The compounds are useful for lowering serum serotonin levels in a patient in need thereof, e.g., to increase bone mass. In preferred embodiments, the patient is known to have, or to be at risk for, a low bone mass disease such as osteoporosis.
Patents:WO 2,011,053,977
Inventor(s):
LANDRY DONALD [US]; DENG SHI-XIAN [US]
Type of Offer:
Licensing
« More Medical Patents